Davide M. Ferraris

This paper introduces LDDM, a generative model for drug design that produces synthetically accessible compounds validated experimentally for five protein targets.

FragmentScope uses learned protein surface representations to guide fragment placement and small molecule design, achieving accurate placement and promising lead compounds.

The paper uses single-molecule imaging and molecular dynamics simulations to study early MET receptor activation in situ, revealing structural dynamics and a refined dimer model.